IQVIA Holdings Inc. (IQV)
After hours:
| Previous close | 238.40 |
| Open | 238.97 |
| Bid | 95.58 x 1400 |
| Ask | 255.00 x 1200 |
| Day's range | 237.19 - 240.62 |
| 52-week range | 167.42 - 261.73 |
| Volume | |
| Avg. volume | 1,191,148 |
| Market cap | 43.515B |
| Beta (5Y monthly) | 1.50 |
| PE ratio (TTM) | 30.96 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative
Signant Health, the leader in evidence generation for modern clinical trials, announced today it has joined IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, in its One Home for Sites™ initiative.
- Business Wire
IQVIA CFO Ron Bruehlman to Speak at the Morgan Stanley Annual Global Healthcare Conference on September 4, 2024
RESEARCH TRIANGLE PARK, N.C., August 21, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Morgan Stanley Annual Healthcare Conference in New York on Wednesday, September 4, 2024 at 10:00 a.m. ET.
- Business Wire
IQVIA Reports Second-Quarter 2024 Results
RESEARCH TRIANGLE PARK, N.C., July 22, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended June 30, 2024.
